about
Consensus statement from the 2014 International Microdialysis ForumGlycolysis and the pentose phosphate pathway after human traumatic brain injury: microdialysis studies using 1,2-(13)C2 glucose.(13)C-labelled microdialysis studies of cerebral metabolism in TBI patients.Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings.Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.Focally perfused succinate potentiates brain metabolism in head injury patientsSerial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applicationsComposite outcomes in cardiovascular research: a survey of randomized trials.Lactate uptake by the injured human brain: evidence from an arteriovenous gradient and cerebral microdialysis study.Traumatic brain injury in England and Wales: prospective audit of epidemiology, complications and standardised mortality.Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.Regional scalp block for postcraniotomy analgesia: a systematic review and meta-analysis.The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.Pharmacologic Management of Subarachnoid Hemorrhage.Cerebrospinal Fluid and Microdialysis Cytokines in Aneurysmal Subarachnoid Hemorrhage: A Scoping Systematic Review.Monitoring the Neuroinflammatory Response Following Acute Brain Injury.Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review.Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development.Temporal profile of intracranial pressure and cerebrovascular reactivity in severe traumatic brain injury and association with fatal outcome: An observational study.Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injuryProposal for establishment of the UK Cranial Reconstruction Registry (UKCRR).Noninvasive monitoring of cerebrovascular reactivity with near infrared spectroscopy in head-injured patients.Spectrum of outcomes following traumatic brain injury-relationship between functional impairment and health-related quality of life.A systematic review of cerebral microdialysis and outcomes in TBI: relationships to patient functional outcome, neurophysiologic measures, and tissue outcome.Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model.Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study.Comment on: 'Pitfalls in microdialysis methodology: an in vitro analysis of temperature, pressure and catheter use'.Fixed, dilated pupils following traumatic brain injury: historical perspectives, causes and ophthalmological sequelae.Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery.What constitutes Clinical Equipoise?Sex and the cytokines: are there fundamental differences in response to brain injury?Concussion and sport.Editorial: Monitoring Pathophysiology in the Injured Brain.Foix-Chavany-Marie syndrome secondary to bilateral traumatic operculum injuryWhat will the ‘creatinine kinase’ be in 2016?A Comparison of Oxidative Lactate Metabolism in Traumatically Injured Brain and Control Brain
P50
Q26801688-41DE5740-BC65-4B92-BFF5-57CC70BE0DC1Q30394858-4F677EEB-BEB4-4314-8A50-E98DD96116ADQ30722189-36B4A726-1876-41E8-885F-8CFEA1005CB8Q30870829-DDD833A2-EBDF-406D-B15F-92A5A756BD63Q33581165-094F98AE-D315-49C2-AEBD-C2C025621DAFQ33828684-418F9EBB-5532-4051-8906-192C348EEF3DQ33863821-D2AFDD85-EA23-4BA6-A195-A3A4BFC45A50Q34627631-0320EBD7-9727-4986-BFE8-01C0C507C720Q35094550-ABE88A12-3200-479D-A7BF-78379B7D61FFQ36123018-1FDD461D-1785-4D0F-962D-70DFD890260DQ36872983-182C5A73-D4F1-4152-9B86-CE934949A78EQ37316312-515E4DF5-4B7B-4327-8047-039DD7B6F11AQ37404280-C97FF9C8-538C-440C-A0ED-AE84A298C3DFQ37516613-21E05745-F7C8-45BE-9AFF-2F57DE2EF737Q37937115-A373C773-AEB6-4CBE-9BF7-55066B1555A7Q38088065-306F7D68-CFB6-4AFC-9E82-D8013FF747D8Q38213375-8644B79D-9B11-4B99-9EB6-A2FBA0836B75Q38363397-E2E2C684-2222-461A-BF7B-48925667B318Q38604879-095EAAA4-A1DC-42B9-9809-2A2DC14F9A7DQ38642078-343F3ECE-03CA-4EED-8B48-1794BA5AD7EAQ38663371-01D9B909-1B98-46B1-953C-5802F81C10BBQ38772493-00EE1D2A-1436-4BBA-B0D1-2807B46218DFQ40109044-EB04C719-1BA5-456E-9D75-B64A25CDC9D1Q42374652-1CDE21DC-49C2-4565-B777-B7B1AAA6FA98Q44441977-33478A63-5E47-4850-B305-9274EBA6C66DQ44842899-5DE71E76-BB97-4C91-8C42-9283EBA2FE8CQ47104382-C958AFBC-7959-4B8B-99A2-A6AF4ABCF4E8Q47109131-96E5DD59-AB5A-4877-A740-E129B9EC2D21Q47864330-3BC02FD6-69E6-4321-B153-BB3FD3106E0BQ48296265-4BC02013-C6CC-48E4-B14D-27635E9DF3DCQ48318924-8EFB6DEE-4880-45F1-BA94-8AA413FC8E9AQ48584098-45743021-B6FF-4625-AFBE-0DF781F91345Q48765969-BD27B79F-AAD3-43C7-9995-65667875084BQ49055281-B50D2414-08A0-4FD0-8BFC-BE7D82F608E8Q49142184-23D56DB3-6B4D-44E3-B24C-73249B525810Q52545819-5E9B1B7C-BD14-47CE-8702-82F3345F36A4Q55088810-A63B69B6-2D56-4A92-8834-652C47EE8FE3Q57452531-A249DCCE-B0CA-4B18-BBFB-402373079ED8Q57721158-2D19E708-CFC3-472E-9C93-8546A03E197AQ58777975-14291ABA-D106-4D79-B3EA-8607CEDB61C7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adel Helmy
@ast
Adel Helmy
@en
Adel Helmy
@es
Adel Helmy
@nl
type
label
Adel Helmy
@ast
Adel Helmy
@en
Adel Helmy
@es
Adel Helmy
@nl
prefLabel
Adel Helmy
@ast
Adel Helmy
@en
Adel Helmy
@es
Adel Helmy
@nl
P108
P106
P108
P1153
16424884100
P31
P496
0000-0002-0531-0556